The discovery of TAFI
PPARγ agonists
Pioglitazone protects against thrombosis in a mouse model of obesity and insulin resistance
An ideal thrombolytic and antithrombotic agent?
A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity – a staphylokinase variant. I. In vitro study
Heparin-independent activation of platelets by HIT antibodies
Activation of platelets by heparin-induced thrombocytopenia antibodies in the serotonin release assay is not dependent on the presence of heparin
Thrombophilia and pregnancy loss in first intended pregnancy
Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy
Platelet G protein-coupled receptors in hemostasis and thrombosis
A rare and misdiagnosed bleeding disorder
High functional levels of thrombin-activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic stroke
Pharmacokinetic studies on Wilfactin®, a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods
Cysteine-mutations in von Willebrand factor associated with increased clearance
Modeling premature occurrence of acute coronary syndrome with atherogenic and thrombogenic risk factors and gene markers in extended families
Long-term treatment with ximelagatran, an oral direct thrombin inhibitor, persistently reduces the coagulation activity after a myocardial infarction
Protein Z plasma levels in different phases of activity of coronary atherosclerosis
Lack of desmopressin (DDAVP) response in men with hemophilia A following liver transplantation
Factor VIIa binding and internalization in hepatocytes
Extra-hepatic factor VIII expression in porcine fulminant hepatic failure
Apo(a) promotes thrombosis in a vascular injury model by a mechanism independent of plasminogen
Thrombotic phenotype of mice with a combined deficiency in plasminogen activator inhibitor 1 and vitronectin
A differential role of the platelet ADP receptors P2Y1 and P2Y12 in Rac activation
Association of the antagonism of von Willebrand factor but not fibrinogen by platelet αIIbβ3 antagonists with prolongation of bleeding time
Impaired platelet function in a patient with P2Y12 deficiency caused by a mutation in the translation initiation codon
Highly constrained cyclic (S,S) -CXaaC- peptides as inhibitors of fibrinogen binding to platelets
Adenine nucleotide metabolism in human blood – important roles for leukocytes and erythrocytes
Cyclooxygenase-1 haplotype modulates platelet response to aspirin
Red blood cell transfusion in patients with type 1 Glanzmann's thrombasthenia
Four cases of hypofibrinogenemia associated with four novel mutations
P2Y1 gene polymorphism and ADP-induced platelet response
Inhibition of thrombin activatable fibrinolysis inhibitor augments fibrinolysis in human whole blood
Fast kinetic assay for the determination of procarboxypeptidase U (TAFI) in human plasma
Placental TFPI is decreased in gestational vascular complications and can be restored by maternal enoxaparin treatment
Characterization of a novel prothrombin variant, Prothrombin C20209T, as a modifier of thrombotic risk among African-Americans
An additional Glu30Lys substitution in the Gla domain of the protein Z gene is not a common polymorphism but a rare mutation, which would cause its deficiency
Performances of the HemosIL D-dimer HS assay for the exclusion of venous thromboembolism
Graduated compression stockings for the prevention of venous thromboembolism in surgical patients in the age of low molecular weight heparins
Is there a need for replacement of the International Reference Preparation for Thromboplastin, Bovine, Combined (OBT/79)?
Postoperative pericardial effusion in patients receiving anticoagulants for deep vein thrombosis after coronary artery bypass graft surgery
More on
Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination – a rebuttal
Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination – reply to a rebuttal
Talking about…